2590-1567

International Journal of Pharmaceutics X

Elsevier

View prefix report (10.1016)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 592 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact592 DOIs
2

Attach ORCID iDs across 562 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact562 DOIs
3

Deposit reference lists for 18 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact18 DOIs

DOIs for this ISSN

Showing the top 5 of 592 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Additive manufacturing technologies with emphasis on stereol… (10.1016/j.ijpx.2023.100159)
Abstract ORCID
105.36 127
2 Digitalization in pharmaceutical industry: What to focus on… (10.1016/j.ijpx.2021.100095)
Abstract ORCID
87.41 55
3 Magnetic nanosystem a tool for targeted delivery and diagnos… (10.1016/j.ijpx.2024.100231)
Abstract ORCID
83.60 46
4 Using zeta potential to study the ionisation behaviour of po… (10.1016/j.ijpx.2019.100024)
Abstract ORCID
83.14 45
5 Bacterially sensitive nanoparticle-based dissolving micronee… (10.1016/j.ijpx.2020.100047)
Abstract ORCID
82.17 43
6 Premium ethylcellulose polymer based architectures at work i… (10.1016/j.ijpx.2019.100023)
Abstract ORCID
79.55 38
7 Advances in the delivery of anticancer drugs by nanoparticle… (10.1016/j.ijpx.2024.100281)
Abstract ORCID
79.55 38
8 Exploiting recent trends for the synthesis and surface funct… (10.1016/j.ijpx.2022.100116)
Abstract ORCID
77.20 34
9 From lab to industrial development of lipid nanocarriers usi… (10.1016/j.ijpx.2024.100266)
Abstract ORCID
75.26 31
10 A synbiotic concept containing spore-forming Bacillus strain… (10.1016/j.ijpx.2019.100021)
Abstract ORCID
73.12 28
11 Accelerating 3D printing of pharmaceutical products using ma… (10.1016/j.ijpx.2022.100120)
Abstract ORCID
73.12 28
12 Comprehensive analysis of lipid nanoparticle formulation and… (10.1016/j.ijpx.2024.100283)
Abstract ORCID
73.12 28
13 Influence of probiotic bacteria on gut microbiota compositio… (10.1016/j.ijpx.2021.100087)
Abstract ORCID
71.57 26
14 The applications of machine learning to predict the forming… (10.1016/j.ijpx.2023.100164)
Abstract ORCID
69.90 24
15 Exploring the landscape of Lipid Nanoparticles (LNPs): A com… (10.1016/j.ijpx.2024.100305)
Abstract ORCID
69.90 24
16 WITHDRAWN: Advances in drug delivery systems: Work in progre… (10.1016/j.ijpx.2020.100050)
Abstract ORCID
69.01 23
17 Predicting pharmaceutical inkjet printing outcomes using mac… (10.1016/j.ijpx.2023.100181)
Abstract ORCID
69.01 23
18 Cod liver oil nano-structured lipid carriers (Cod-NLCs) as a… (10.1016/j.ijpx.2023.100160)
Abstract ORCID
67.12 21
19 QbD-guided phospholipid-tagged nanonized boswellic acid natu… (10.1016/j.ijpx.2024.100257)
Abstract ORCID
66.11 20
20 The role interplay between mesoporous silica pore volume and… (10.1016/j.ijpx.2019.100008)
Abstract ORCID
65.05 19
21 Ultra-sensitive pH responsive hydrogels with injectable and… (10.1016/j.ijpx.2025.100334)
Abstract ORCID
65.05 19
22 Characterisation of niosome nanoparticles prepared by microf… (10.1016/j.ijpx.2022.100137)
Abstract ORCID
63.94 18
23 Towards 4D printing in pharmaceutics (10.1016/j.ijpx.2023.100171)
Abstract ORCID
63.94 18
24 Exploring the potential of antifungal-loaded proniosomes to… (10.1016/j.ijpx.2025.100322)
Abstract ORCID
63.94 18
25 Development and characterization of fenticonazole nitrate-lo… (10.1016/j.ijpx.2025.100355)
Abstract ORCID
63.94 18
26 Novel hybrid tri-polymer hyalurosomes: unlocking next-genera… (10.1016/j.ijpx.2025.100425)
Abstract ORCID
63.94 18
27 In vivo pharmacokinetic study of remdesivir dry powder for i… (10.1016/j.ijpx.2021.100073)
Abstract ORCID
62.76 17
28 Development and optimization of vildagliptin solid lipid nan… (10.1016/j.ijpx.2024.100232)
Abstract ORCID
62.76 17
29 Terconazole loaded edge-activated hybrid elastosome for reva… (10.1016/j.ijpx.2025.100333)
Abstract ORCID
62.76 17
30 FDA’s new pharmaceutical quality initiative: Knowledge-aided… (10.1016/j.ijpx.2019.100010)
Abstract ORCID
61.52 16
31 Intracochlear PLGA based implants for dexamethasone release:… (10.1016/j.ijpx.2019.100015)
Abstract ORCID
61.52 16
32 Mean yield pressure from the in-die Heckel analysis is a rel… (10.1016/j.ijpx.2021.100094)
Abstract ORCID
61.52 16
33 Nanoparticles design considerations to co-deliver nucleic ac… (10.1016/j.ijpx.2022.100126)
Abstract ORCID
61.52 16
34 Oxidation of polysorbates – An underestimated degradation pa… (10.1016/j.ijpx.2023.100202)
Abstract ORCID
61.52 16
35 Advances in nano drug delivery systems for enhanced efficacy… (10.1016/j.ijpx.2024.100314)
Abstract ORCID
61.52 16
36 Revolutionary hyaluronic acid-modified edge-activated spanla… (10.1016/j.ijpx.2025.100430)
Abstract ORCID
60.21 15
37 Simultaneous fabrication of multiple tablets within seconds… (10.1016/j.ijpx.2023.100166)
Abstract ORCID
58.80 14
38 Dual-effects of caffeinated hyalurosomes as a nano-cosmeceut… (10.1016/j.ijpx.2023.100170)
Abstract ORCID
58.80 14
39 Amorphous solid dispersion formation via solvent granulation… (10.1016/j.ijpx.2019.100035)
Abstract ORCID
57.31 13
40 Formulation development of itraconazole PEGylated nano-lipid… (10.1016/j.ijpx.2021.100074)
Abstract ORCID
57.31 13
41 Intravesical drug delivery approaches for improved therapy o… (10.1016/j.ijpx.2021.100100)
Abstract ORCID
57.31 13
42 To infinity and beyond: Strategies for fabricating medicines… (10.1016/j.ijpx.2022.100121)
Abstract ORCID
57.31 13
43 Development of 3D-printed vaginal devices containing metroni… (10.1016/j.ijpx.2022.100142)
Abstract ORCID
57.31 13
44 Releasing fast and slow: Non-destructive prediction of densi… (10.1016/j.ijpx.2022.100148)
Abstract ORCID
57.31 13
45 Antibiotic-loaded hydroxyapatite scaffolds fabricated from N… (10.1016/j.ijpx.2023.100169)
Abstract ORCID
57.31 13
46 Formulation, optimization and evaluation of ocular gel conta… (10.1016/j.ijpx.2023.100228)
Abstract ORCID
57.31 13
47 Augmented glycerosomes as a promising approach against funga… (10.1016/j.ijpx.2024.100295)
Abstract ORCID
57.31 13
48 Nanoparticle technologies in precision oncology and personal… (10.1016/j.ijpx.2025.100353)
Abstract ORCID
57.31 13
49 Impact of electroviscous effect on viscosity in developing h… (10.1016/j.ijpx.2018.100002)
Abstract ORCID
55.70 12
50 Biophysical model to predict lung delivery from a dual bronc… (10.1016/j.ijpx.2019.100018)
Abstract ORCID
55.70 12